Houman Javedan, M.B.,Ch.B.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Geriatric Assessment | 10 | 2022 | 1409 | 1.220 |
Why?
|
Frail Elderly | 5 | 2021 | 763 | 0.970 |
Why?
|
Geriatrics | 3 | 2021 | 388 | 0.710 |
Why?
|
Efficiency | 1 | 2022 | 476 | 0.640 |
Why?
|
Fracture Healing | 1 | 2017 | 445 | 0.470 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 411 | 0.410 |
Why?
|
Delirium | 4 | 2020 | 1667 | 0.400 |
Why?
|
Fracture Fixation, Internal | 1 | 2017 | 969 | 0.360 |
Why?
|
Perioperative Care | 1 | 2018 | 1034 | 0.350 |
Why?
|
Quality Improvement | 3 | 2021 | 3800 | 0.330 |
Why?
|
Hip Fractures | 2 | 2014 | 988 | 0.320 |
Why?
|
Anesthesiology | 2 | 2019 | 1117 | 0.310 |
Why?
|
Preoperative Care | 3 | 2019 | 2242 | 0.230 |
Why?
|
Traumatology | 2 | 2021 | 100 | 0.210 |
Why?
|
Holistic Health | 1 | 2021 | 48 | 0.190 |
Why?
|
Postoperative Complications | 4 | 2018 | 15647 | 0.190 |
Why?
|
Trauma Centers | 2 | 2017 | 937 | 0.190 |
Why?
|
Hematologic Neoplasms | 2 | 2022 | 1896 | 0.160 |
Why?
|
Dura Mater | 1 | 2020 | 290 | 0.160 |
Why?
|
Proxy | 1 | 2019 | 151 | 0.150 |
Why?
|
Aged, 80 and over | 13 | 2022 | 58946 | 0.140 |
Why?
|
Fractures, Bone | 2 | 2021 | 2046 | 0.140 |
Why?
|
Risk Assessment | 5 | 2020 | 23981 | 0.140 |
Why?
|
Musculoskeletal System | 1 | 2019 | 188 | 0.140 |
Why?
|
Sarcopenia | 1 | 2021 | 372 | 0.140 |
Why?
|
Disease Management | 2 | 2019 | 2504 | 0.130 |
Why?
|
Laminectomy | 1 | 2016 | 225 | 0.120 |
Why?
|
Program Development | 1 | 2021 | 1298 | 0.120 |
Why?
|
Aged | 19 | 2022 | 169179 | 0.120 |
Why?
|
Length of Stay | 5 | 2020 | 6422 | 0.110 |
Why?
|
Patients | 1 | 2019 | 906 | 0.100 |
Why?
|
Mass Screening | 2 | 2019 | 5428 | 0.100 |
Why?
|
Osteoporosis | 1 | 2021 | 1605 | 0.100 |
Why?
|
Patient-Centered Care | 1 | 2021 | 1419 | 0.090 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 2021 | 1410 | 0.090 |
Why?
|
Decompression, Surgical | 1 | 2016 | 608 | 0.090 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2021 | 1384 | 0.090 |
Why?
|
Feasibility Studies | 1 | 2021 | 5247 | 0.090 |
Why?
|
Patient Care Planning | 1 | 2016 | 908 | 0.090 |
Why?
|
Accidental Falls | 1 | 2017 | 1068 | 0.080 |
Why?
|
Neurosurgical Procedures | 1 | 2020 | 2071 | 0.080 |
Why?
|
Patient Care Team | 1 | 2020 | 2523 | 0.080 |
Why?
|
Analysis of Variance | 1 | 2017 | 6231 | 0.080 |
Why?
|
Orthopedic Procedures | 1 | 2017 | 1264 | 0.070 |
Why?
|
Referral and Consultation | 2 | 2022 | 3597 | 0.070 |
Why?
|
Decision Making | 2 | 2021 | 3929 | 0.070 |
Why?
|
Patient Readmission | 2 | 2017 | 3267 | 0.070 |
Why?
|
Evidence-Based Medicine | 1 | 2018 | 3687 | 0.060 |
Why?
|
Cognition Disorders | 2 | 2017 | 3979 | 0.060 |
Why?
|
Patient Acceptance of Health Care | 1 | 2019 | 3204 | 0.060 |
Why?
|
Humans | 23 | 2022 | 761326 | 0.060 |
Why?
|
Cognition | 2 | 2019 | 6987 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15262 | 0.060 |
Why?
|
Male | 12 | 2021 | 360621 | 0.060 |
Why?
|
Sex Factors | 1 | 2018 | 10551 | 0.060 |
Why?
|
Pain | 1 | 2019 | 5077 | 0.060 |
Why?
|
Telemedicine | 1 | 2021 | 3041 | 0.050 |
Why?
|
Wounds and Injuries | 1 | 2016 | 2490 | 0.050 |
Why?
|
Prognosis | 3 | 2018 | 29588 | 0.050 |
Why?
|
Female | 11 | 2021 | 392485 | 0.050 |
Why?
|
Gamma Cameras | 1 | 2002 | 34 | 0.050 |
Why?
|
Erythema | 1 | 2003 | 262 | 0.050 |
Why?
|
Thyroglobulin | 1 | 2002 | 111 | 0.050 |
Why?
|
Skin Pigmentation | 1 | 2003 | 277 | 0.050 |
Why?
|
Cohort Studies | 3 | 2020 | 41440 | 0.050 |
Why?
|
Radiation Tolerance | 1 | 2003 | 479 | 0.050 |
Why?
|
Obesity, Abdominal | 1 | 2021 | 374 | 0.040 |
Why?
|
Ultraviolet Rays | 1 | 2003 | 1079 | 0.040 |
Why?
|
Iodine Radioisotopes | 1 | 2002 | 1033 | 0.040 |
Why?
|
Age Factors | 3 | 2020 | 18401 | 0.040 |
Why?
|
Inappropriate Prescribing | 1 | 2020 | 212 | 0.040 |
Why?
|
Polypharmacy | 1 | 2020 | 305 | 0.040 |
Why?
|
Trauma Severity Indices | 1 | 2019 | 478 | 0.040 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2019 | 395 | 0.030 |
Why?
|
Inservice Training | 1 | 2019 | 375 | 0.030 |
Why?
|
Prospective Studies | 5 | 2019 | 54405 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2021 | 1668 | 0.030 |
Why?
|
Time Factors | 1 | 2017 | 39974 | 0.030 |
Why?
|
Risk Factors | 3 | 2020 | 74152 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2017 | 64645 | 0.030 |
Why?
|
Morbidity | 1 | 2019 | 1750 | 0.030 |
Why?
|
Retrospective Studies | 2 | 2020 | 80575 | 0.030 |
Why?
|
Body Composition | 1 | 2021 | 2422 | 0.030 |
Why?
|
Radiopharmaceuticals | 1 | 2002 | 2650 | 0.030 |
Why?
|
Lumbar Vertebrae | 1 | 2020 | 1879 | 0.020 |
Why?
|
Interdisciplinary Communication | 1 | 2016 | 931 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2019 | 2421 | 0.020 |
Why?
|
Hospitalization | 2 | 2022 | 10715 | 0.020 |
Why?
|
Terminal Care | 1 | 2021 | 1760 | 0.020 |
Why?
|
Thyroid Neoplasms | 1 | 2002 | 2332 | 0.020 |
Why?
|
Patient Admission | 1 | 2016 | 1367 | 0.020 |
Why?
|
Societies, Medical | 1 | 2020 | 3905 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2014 | 1440 | 0.020 |
Why?
|
Palliative Care | 1 | 2021 | 3592 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8837 | 0.020 |
Why?
|
Health Personnel | 1 | 2019 | 3335 | 0.020 |
Why?
|
Survival Rate | 1 | 2019 | 12710 | 0.010 |
Why?
|
Neuropsychological Tests | 1 | 2017 | 7045 | 0.010 |
Why?
|
Exercise | 1 | 2020 | 5883 | 0.010 |
Why?
|
Intensive Care Units | 1 | 2016 | 3744 | 0.010 |
Why?
|
Incidence | 1 | 2020 | 21336 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2016 | 5291 | 0.010 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2003 | 882 | 0.010 |
Why?
|
Melanins | 1 | 2003 | 289 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2019 | 20092 | 0.010 |
Why?
|
Adenoma, Oxyphilic | 1 | 2002 | 148 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2021 | 26108 | 0.010 |
Why?
|
Quality of Life | 1 | 2021 | 13355 | 0.010 |
Why?
|
Adenocarcinoma, Follicular | 1 | 2002 | 323 | 0.010 |
Why?
|
Thyroxine | 1 | 2002 | 668 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2021 | 20555 | 0.010 |
Why?
|
Models, Biological | 1 | 2014 | 9468 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2019 | 39108 | 0.010 |
Why?
|
Carcinoma, Papillary | 1 | 2002 | 784 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2002 | 4908 | 0.010 |
Why?
|
Skin | 1 | 2003 | 4482 | 0.010 |
Why?
|
Middle Aged | 1 | 2002 | 220774 | 0.000 |
Why?
|